Navigation Links
Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
Date:6/24/2009

MORRISTOWN, N.J., June 24 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for levonorgestrel tablets, 0.75 mg, for women seventeen years and younger. Levonorgestrel is the generic equivalent to Duramed Pharmaceuticals' PLAN B(R), which is indicated for the prevention of pregnancy following unprotected intercourse or contraceptive failure. This product is approved for prescription use only. The Company intends to market the product under the trade name Next Choice(TM) and plans to launch the product shortly. For the 12-months ending March 2009, PLAN B(R) had total U.S. sales of approximately $123 million, of which approximately ten percent are attributable to prescription sales, according to IMS sales data. PLAN B(R) over-the-counter (O.T.C.) new product exclusivity expires on August 24, 2009.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement

Any statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and informati
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Watson to Acquire Arrow Group
2. Watson Files FDA Application for Generic Mucinex(R) D
3. Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
4. Watson-Marlow Releases Informative Video Featuring Showcased High Purity Pumps, Tubing and Fillers at Interphex 2009
5. Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
6. Watson Files FDA Applications for Generic Mucinex(R)
7. Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting
8. Companies Continue To Add Wellness Programs, Watson Wyatt/National Business Group On Health Survey Finds
9. Mark G. Watson Named Executive Director of Radiological Society of North America
10. Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
11. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... (PRWEB) November 27, 2014 Jeffrey ... years in the Charlotte area providing audits, reviews, ... services to businesses of varying size across numerous ... owners to meet all of their accounting and ... through the QuickBooks ProAdvisor Program. When asking Mr. ...
(Date:11/27/2014)... 2014 “Wekho” was featured on NewsWatch as ... coolest mobile applications on the iOS, Android, and Windows markets. ... conducted the app review and shared with viewers ... , An interesting new way to travel and experience the ... It’s called Wekho and it’s a free geolocation app ...
(Date:11/27/2014)... Burnsville MN (PRWEB) November 27, 2014 ... manufacturer of office ergonomics equipment , has announced ... partnership with Commercial Office Environments. The partnership will ... for office furnishings location. , In addition to ... the new dealer partnership promotes HealthPostures' products with ...
(Date:11/27/2014)... 27, 2014 RBSEO Services, a ... engine optimization service just at $99. RBSEO Services ... cannot afford costly search engine optimization service. So, ... their affordablity and requirements into consideration. , ... it has not compromised with the service quality. ...
(Date:11/27/2014)... 26, 2014 Lintelus, Inc., an ... focused on increasing audience engagement at Convergence Summit ... software platform includes a multitude of interactive features ... a collaborative, interactive multi-screen environment. Best of all, ... in real time on their own device. , ...
Breaking Medicine News(10 mins):Health News:Jeffrey Carlini becomes Intuit Proadvisor and receives QuickBooks certification 2Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2Health News:RBSEO Services Announces SEO Services at $99 Only 2Health News:Lintelus Showcases its Feature-Rich Presentation Technology Solution at Convergence Summit’s Annual Event in London 2
... a critical genetic factor in the control of many ... deleted a genetic factor// , called a microRNA, in ... cardiovascular differentiation and development. ,MicroRNAS, or ... to fine-tune levels of important proteins in cells. To ...
... Living Cell Technologies Limited outlines the survival and identification of ... patient 10 years after receiving a pig islet cell transplant. ... demonstrated the long-term safety, viability and function of its encapsulated ... of time, without the use of immunosuppression. ...
... (April 20 from the researchers from Yale School of ... for the first time found evidence of a// molecular ... network connections. ,This discovery may help the ... normal aging, and for cognitive changes in schizophrenia, bipolar ...
... scarcity has become a universal problem. With a view ... taken up in the country.// ,In a press ... annual rainfall in India is about 1170 mm. However, ... ,The release further said that there had been ...
... has launched, dedicated to all aspiring souls with interest ... and wellness//. Founded by a personal fitness trainer turned ... inspired by her own healing process, it became the ... that educates, inspires, nurtures, and stimulates the mind, body, ...
... be seen as an effective antidote to the more formal ... more easily// accessible. According to a new survey, at least ... clinic, and that figure will likely rise, a new poll ... of 2,076 U.S. adults. Knowledge Networks conducted the poll in ...
Cached Medicine News:Health News:Scientists Identify Critical Gene Factor in Heart Development 2Health News:LCT Reports Major Step for Islet Transplantation in Diabetes Patient 2Health News:LCT Reports Major Step for Islet Transplantation in Diabetes Patient 3Health News:New Light on Working of Brain Networks 2Health News:New Light on Working of Brain Networks 3Health News:Stress on Storage and Conservation of Rain Water by Govt of India 2Health News:Retail Clinics Becoming Increasingly Popular in US 2
(Date:11/26/2014)... Nov. 26, 2014  Genomic Health, Inc. (Nasdaq: ... Chairman, Chief Executive Officer and President, will participate in ... at The New York Palace Hotel in ... 11:30 am Eastern Time (ET). To access ... call, go to the  Investor Relations  section of the ...
(Date:11/26/2014)... VIEJO, Calif. , Nov. 26, 2014 /PRNewswire/ ... announced that the U.S. Food and Drug Administration ... its New Drug Application (NDA) for AVP-825. AVP-825 ... low-dose sumatriptan powder delivered intranasally utilizing a novel ... the Complete Response letter, and consistent with the ...
(Date:11/26/2014)... 26, 2014 Scott Steiger lives in ... world. As an engineer for the past 20 years, he,s traveled ... military service. He,s been to six of the seven continents. Travel ... - http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 ... has a pretty good idea of what,s required. His ...
Breaking Medicine Technology:Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4Steiger Has Created the First Pill Case Specifically Designed For Travel 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: